Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma

Journal of the American Academy of Dermatology

Volumn 63, Issue 2, 2010, Pages

  Kenner Bell, Brandi M ^a   Paller, Amy S ^a   Lacouture, Mario E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; KERATOLYTIC AGENT; RETINOID; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ADULT; ALOPECIA; CASE REPORT; FEMALE; FLEXION CONTRACTURE; HUMAN; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; LETTER; OLMSTED SYNDROME; PALMOPLANTAR KERATODERMA; PARONYCHIA; PRIORITY JOURNAL; RANGE OF MOTION; STRATUM CORNEUM; XEROSIS; DRUG ANTAGONISM; HAND DISEASE;

ADULT; FEMALE; HAND DERMATOSES; HUMANS; KERATODERMA, PALMOPLANTAR; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 77955284190     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.10.052     Document Type: Article

References (5)

1. M. Larrègue, V. Callot, J. Kanitakis, A.M. Suau, and M. Foret Olmsted syndrome: report of two new cases and literature review J Dermatol 27 2000 557 568
2. A.R. Tan, X. Yang, S.M. Hewitt, A. Berman, E.R. Lepper, and A. Sparreboom et al. Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor J Clin Oncol 22 2004 3080 3090
3. S. Yano, K. Kondo, M. Yamaguchi, G. Richmond, M. Hutchison, and A. Wakeling et al. Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition Anticancer Res 23 2003 3639 3650
4. L. Requena, F. Manzarbeitia, C. Moreno, M.J. Izquierdo, M.A. Pastor, and L. Carrasco Olmsted syndrome: report of a case with study of the cellular proliferation in keratoderma Am J Dermatopathol 23 2001 514 520 (Pubitemid 33086479)
5. Drugstore.com online pharmacy web site. Available at: http://www.drugstore.com. Accessed September 3, 2009.